Cyrmenin B2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-01131 |
| CAS | 672929-30-5 |
| Molecular Weight | 392.49 |
| Molecular Formula | C21H32N2O5 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Cystobacter armeniaca Cb a24, Archangium gephyra Ar 9944. It is a β-methoxy acrylic acid (MOA) inhibitor. Cyrmenin B2 inhibits NADH oxidation of bovine heart submitochondrial particles with IC50 of 159 ng/mL. The mechanism is to block the bc1 phase of electron transport in the respiratory chain.
- Specification
- Properties
- Price Product List
| IUPAC Name | methyl (Z)-2-[2-[[(2E,4Z)-2,10-dimethylundeca-2,4-dienoyl]amino]prop-2-enoylamino]-3-methoxyprop-2-enoate |
| Canonical SMILES | CC(C)CCCCC=CC=C(C)C(=O)NC(=C)C(=O)NC(=COC)C(=O)OC |
| InChI | InChI=1S/C21H32N2O5/c1-15(2)12-10-8-7-9-11-13-16(3)19(24)22-17(4)20(25)23-18(14-27-5)21(26)28-6/h9,11,13-15H,4,7-8,10,12H2,1-3,5-6H3,(H,22,24)(H,23,25)/b11-9-,16-13+,18-14- |
| InChI Key | PERDMKQFFPTEJL-PFSSXTEVSA-N |
| Appearance | Oily Matter |
| Antibiotic Activity Spectrum | Fungi |
| Solubility | Soluble in Ethanol |
| BBF-01729 | Hygromycin B | Inquiry |
| BBF-01732 | Mevastatin | Inquiry |
| BBF-03915 | Clavulanate Potassium (1:1 mixture with silicon dioxide) | Inquiry |
| BBF-03937 | Pirarubicin | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-00852 | Epothilon B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
